Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 Pandemic

Cristina Garcia-Maurino; Helena Brenes-Chacón; Katia C Halabi; Pablo J Sánchez; Octavio Ramilo; Asuncion Mejias

doi:10.1001/jamapediatrics.2023.5431

Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 Pandemic

JAMA Pediatr. 2024 Feb 1;178(2):195-197. doi: 10.1001/jamapediatrics.2023.5431.

Authors

Cristina Garcia-Maurino¹, Helena Brenes-Chacón², Katia C Halabi³, Pablo J Sánchez⁴, Octavio Ramilo⁵, Asuncion Mejias⁵

Affiliations

¹ Institute for Global Health, University College London, London, United Kingdom.
² Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus.
³ Division of Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio.
⁴ Division of Neonatology, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio.
⁵ Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.

PMID: 38079156
PMCID: PMC10714280 (available on 2024-12-11)
DOI: 10.1001/jamapediatrics.2023.5431

No abstract available

Plain language summary

This cohort study evaluates respiratory syncytial virus (RSV)–related hospitalizations and disease severity from 2012 to 2023 in children younger than 5 years.

MeSH terms

COVID-19*
Child
Hospitalization
Humans
Infant
Pandemics
Patient Acuity
Respiratory Syncytial Virus Infections* / epidemiology
Respiratory Tract Infections* / epidemiology

Plain language summary

MeSH terms

Grants and funding